Adiponectin Promotes Functional Recovery after Podocyte Ablation

被引:143
作者
Rutkowski, Joseph M. [1 ]
Wang, Zhao V. [1 ]
Park, Ae Seo Deok [6 ]
Zhang, Jianning [2 ]
Zhang, Dihua [2 ,5 ]
Hu, Ming Chang [2 ,5 ]
Moe, Orson W. [2 ,3 ,5 ]
Susztak, Katalin [6 ]
Scherer, Philipp E. [1 ,2 ,4 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Touchstone Diabet Ctr, Dallas, TX 75390 USA
[2] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA
[3] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA
[4] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA
[5] Univ Texas SW Med Ctr Dallas, Charles & Jane Pak Ctr Mineral Metab & Clin Res, Dallas, TX 75390 USA
[6] Univ Penn, Dept Med, Perelman Sch Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2013年 / 24卷 / 02期
基金
美国国家卫生研究院;
关键词
CHRONIC KIDNEY-DISEASE; ADIPOSE-TISSUE; SEGMENTAL GLOMERULOSCLEROSIS; ANIMAL-MODELS; MOUSE MODEL; OBESITY; ALBUMINURIA; PROTEINURIA; APOPTOSIS; DELETION;
D O I
10.1681/ASN.2012040414
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Low levels of the adipocyte-secreted protein adiponectin correlate with albuminuria in both mice and humans, but whether adiponectin has a causative role in modulating renal disease is unknown. Here, we first generated a mouse model that allows induction of caspase-8-mediated apoptosis specifically in podocytes upon injection of a construct-specific agent. These POD-ATTAC mice exhibited significant kidney damage, mimicking aspects of human renal disease, such as foot process effacement, mesangial expansion, and glomerulosclerosis. After the initial induction, both podocytes and filtration function recovered. Next, we crossed POD-ATTAC mice with mice lacking or overexpressing adiponectin. POD-ATTAC mice lacking adiponectin developed irreversible albuminuria and renal failure; conversely, POD-ATTAC mice overexpressing adiponectin recovered more rapidly and exhibited less interstitial fibrosis. In conclusion, these results suggest that adiponectin is a renoprotective protein after podocyte injury. Furthermore, the POD-ATTAC mouse provides a platform for further studies, allowing precise timing of podocyte injury and regeneration. J Am Soc Nephrol 24: 268-282, 2013. doi: 10.1681/ASN.2012040414
引用
收藏
页码:268 / 282
页数:15
相关论文
共 56 条
[21]   Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin [J].
Holland, William L. ;
Miller, Russell A. ;
Wang, Zhao V. ;
Sun, Kai ;
Barth, Brian M. ;
Bui, Hai H. ;
Davis, Kathryn E. ;
Bikman, Benjamin T. ;
Halberg, Nils ;
Rutkowski, Joseph M. ;
Wade, Mark R. ;
Tenorio, Vincent M. ;
Kuo, Ming-Shang ;
Brozinick, Joseph T. ;
Zhang, Bei B. ;
Birnbaum, Morris J. ;
Summers, Scott A. ;
Scherer, Philipp E. .
NATURE MEDICINE, 2011, 17 (01) :55-U226
[22]   Klotho Deficiency Causes Vascular Calcification in Chronic Kidney Disease [J].
Hu, Ming Chang ;
Shi, Mingjun ;
Zhang, Jianning ;
Quinones, Henry ;
Griffith, Carolyn ;
Kuro-o, Makoto ;
Moe, Orson W. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 22 (01) :124-136
[23]   Antidiabetic prescribing trends and predictors of thiazolidinedione discontinuation following the 2007 rosiglitazone safety alert [J].
Hurren, Kathryn M. ;
Taylor, Thomas N. ;
Jaber, Linda A. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 93 (01) :49-55
[24]   Obesity-associated improvements in metabolic profile through expansion of adipose tissue [J].
Kim, Ja-Young ;
De Wall, Esther Van ;
Laplante, Mathieu ;
Azzara, Anthony ;
Trujillo, Maria E. ;
Hofmann, Susanna M. ;
Schraw, Todd ;
Durand, Jorge L. ;
Li, Hua ;
Li, Guangyu ;
Jelicks, Linda A. ;
Mehler, Mark F. ;
Hui, David Y. ;
Deshaies, Yves ;
Shulman, Gerald I. ;
Schwartz, Gary J. ;
Scherer, Philipp E. .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (09) :2621-2637
[25]   Rapid development of severe end-organ damage in C57BL/6 mice by combining DOCA salt and angiotensin II [J].
Kirchhoff, F. ;
Krebs, C. ;
Abdulhag, U. N. ;
Meyer-Schwesinger, C. ;
Maas, R. ;
Helmchen, U. ;
Hilgers, K. F. ;
Wolf, G. ;
Stahl, R. A. K. ;
Wenzel, U. .
KIDNEY INTERNATIONAL, 2008, 73 (05) :643-650
[26]   Pathogenesis of nonimmune glomerulopathies [J].
Kwoh, Christopher ;
Shannon, M. Brendan ;
Miner, Jeffrey H. ;
Shaw, Andrey .
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2006, 1 (01) :349-374
[27]   Serum adiponectin complexes and cardiovascular risk in children with chronic kidney disease [J].
Lo, Megan M. ;
Salisbury, Shelia ;
Scherer, Philipp E. ;
Furth, Susan L. ;
Warady, Bradley A. ;
Mitsnefes, Mark M. .
PEDIATRIC NEPHROLOGY, 2011, 26 (11) :2009-2017
[28]   Transgenic mice expressing nitroreductase gene under the control of the podocin promoter: a new murine model of inductible glomerular injury [J].
Macary, Guillaume ;
Rossert, Jerome ;
Bruneval, Patrick ;
Mandet, Chantal ;
Belair, Marie-France ;
Houillier, Pascal ;
Van Huyen, Jean-Paul Duong .
VIRCHOWS ARCHIV, 2010, 456 (03) :325-337
[29]   Obesity Related Kidney Disease [J].
Mathew, Anna V. ;
Okada, Shinichi ;
Sharma, Kumar .
CURRENT DIABETES REVIEWS, 2011, 7 (01) :41-49
[30]   Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocyte-specific injury [J].
Matsusaka, T ;
Xin, J ;
Niwa, S ;
Kobayashi, K ;
Akatsuka, A ;
Hashizume, H ;
Wang, QC ;
Pastan, I ;
Fogo, AB ;
Ichikawa, I .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (04) :1013-1023